TVP as prerequisite for Push-Dose Pressors (?)

Not to derail my own thread but my original question has largely been answered and I feel like jumping on the band-wagon...

I think there’s a lot for EMS to take from the EmCrit podcasts. In addition to the examples already listed, my personal favourite is his position people should always use generic drug names not trade names; I’ve been waving this flag for a while. It’s a simple practice that can reduce drug errors and patient harm.
 
CWATT said:
Not to derail my own thread but my original question has largely been answered and I feel like jumping on the band-wagon...

I think there’s a lot for EMS to take from the EmCrit podcasts. In addition to the examples already listed, my personal favourite is his position people should always use generic drug names not trade names; I’ve been waving this flag for a while. It’s a simple practice that can reduce drug errors and patient harm.
Click to expand...

It's only the generation of providers that use drugs after they come off of patent and marketed under generic names that utilize generic nomenclature. New drugs are marketed and prescribed under trade names because of the conditioning by sales reps, trade journals etc. When I trained in anesthesia, the folks that held the position I now hold would use terms like Sublimaze and Norcuron. I and my generation don't. I still say Versed and Diprivan and Zemuron. The younger set coming after me don't. I don't know anyone at all that says apixaban. Just the way the industry is. Old habits die hard.
 
Some names are just easier to say, that's literally how I decided to choose one over the other.
 
You must log in or register to reply here.
Back
Top